• Medicine
  • 22. April
  • FDA to approve Grace Therapeutics' GTx-104
    2
  • FDA to approve Sanofi's Subcutaneous Sarclisa
    2
  • 26. April
  • FDA to approve Sanofi's Dupixent
    2
  • 28. April
  • FDA to approve Sanofi's Tzield
    2
  • 29. April
  • FDA to approve Axsome Therapeutics AXS-05
    2
  • 30. Dezember
  • CDC to issue Level 3 warning by December 31
    2
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2